Clinical trial
Therapy Based on Stage of Disease and Risk Assessment in Treating Children With…
NCT00002802 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00002802 |
|---|---|
| Title | Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma |
| Official title | PHASE III MULTICENTRE TRIAL OF TREATMENT OF NEUROBLASTOMA IN CHILDREN AND ADOLESCENTS |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carboplatin, cisplatin, cyclophosphamide, dacarbazine, doxorubicin hydrochloride, etoposide, ifosfamide, melphalan, mesna, vincristine sulfate and 7 more |
| Enrollment | 500 |
| Start date | Jul 1, 1990 |
| Completion | Sep 1, 2003 |
| First posted | May 12, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: